Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Minn. 340B report finds hundreds of millions in net revenue; authors call for more data
Summary
A first‑of‑its‑kind state report showed Minnesota covered entities generated an estimated $630 million in 340B net revenue in 2023 but flagged missing data that may undercount revenue from office‑administered specialty drugs; the report calls for additional reporting and analysis.
Stefan Gildemeister, director of the Health Economics Program, told the Senate Health and Human Services Committee that Minnesota’s first statutory 340B report finds substantial net revenue flowing to covered entities but that estimates are likely understated because most entities did not report office‑administered specialty drugs.
Gildemeister said the report was requested after 2023 policy debates about changing how the Medicaid prescription drug benefit is delivered. The statute required MDH to collect data on 340B revenue by entity and payer and produce a legislative report; the first report focuses on 2023 flows. He emphasized the work’s purpose was transparency to inform future policy…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
